Search This Blog

Saturday, September 29, 2018

Cantor Fitzgerald Starts PTC Therapeutics (PTCT) at Overweight


Cantor Fitzgerald analyst Alethia Young initiates coverage on PTC Therapeutics (NASDAQ: PTCT) with a Overweight

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.